Yale University: Advancing Therapies for Pulmonary Fibrosis
August 25, 2025
August 25, 2025
NEW HAVEN, Connecticut, Aug. 25 -- Yale University issued the following news release:
* * *
Advancing Therapies for Pulmonary Fibrosis
Pulmonary fibrosis is a condition that causes scarring of the lungs. It is often accompanied by shortness of breath, cough, rapid loss of lung function, and respiratory failure.
Currently, there are only two FDA-approved medications for treating the chronic fibrotic lung disease. These drugs slow down the progre . . .
* * *
Advancing Therapies for Pulmonary Fibrosis
Pulmonary fibrosis is a condition that causes scarring of the lungs. It is often accompanied by shortness of breath, cough, rapid loss of lung function, and respiratory failure.
Currently, there are only two FDA-approved medications for treating the chronic fibrotic lung disease. These drugs slow down the progre . . .